CORRECTION article

Front. Cell. Infect. Microbiol., 17 November 2022

Sec. Intestinal Microbiome

Volume 12 - 2022 | https://doi.org/10.3389/fcimb.2022.1021676

Corrigendum: Lycium barbarum Glycopeptide prevents the development and progression of acute colitis by regulating the composition and diversity of the gut microbiota in mice

  • 1. Beijing Advanced Innovation Centre for Soft Matter Science and Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China

  • 2. Institute of Medical Biology, Chinese Academy of Medical Sciences, Peking Union Medical College, Kunming, China

  • 3. Tianren Goji Biotechnology Co., Ltd, Ningxia, China

  • 4. Guangdong-Hongkong-Macau Institute of Central Nervous System (CNS) Regeneration, Ministry of Education Central Nervous System (CNS) Regeneration Collaborative Joint Laboratory, Jinan University, Guangzhou, China

Article metrics

View details

4

Citations

2,1k

Views

732

Downloads

Error in figure/table

In the published article, there was an error in Figure 7 as published. Figure 7E was incorrectly placed as Figure 7G and Figure 7G appeared twice by mistake. The corrected Figure 7 and its caption appear below.

Figure 7

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

ulcerative colitis, gut microbiota, traditional Chinese medicine, 16S rDNA sequence, inflammation

Citation

Huang Y, Zheng Y, Yang F, Feng Y, Xu K, Wu J, Qu S, Yu Z, Fan F, Huang L, Qin M, He Z, Nie K and So K-F (2022) Corrigendum: Lycium barbarum Glycopeptide prevents the development and progression of acute colitis by regulating the composition and diversity of the gut microbiota in mice. Front. Cell. Infect. Microbiol. 12:1021676. doi: 10.3389/fcimb.2022.1021676

Received

17 August 2022

Accepted

06 October 2022

Published

17 November 2022

Volume

12 - 2022

Edited by

Gianluca Ianiro, Agostino Gemelli University Polyclinic (IRCCS), Italy

Reviewed by

Benedetta Falasca, policlinico universitario Agostino gemelli, Italy; Chuanxin Sun, Institute of Biophysics (CAS), China

Updates

Copyright

*Correspondence: Kaili Nie, ; Zhanlong He,

†These authors have contributed equally to this work

This article was submitted to Intestinal Microbiome, a section of the journal Frontiers in Cellular and Infection Microbiology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics